QuantLogix ← ALB scorecard
📅 ALB Earnings Preview
Albemarle Corporation
Next report (est.)
11/04/2026
Countdown
8 days
EPS growth YoY
+2300.0%
Revenue growth YoY
+31.1%
Options-implied earnings move
±5.0%
The at-the-money straddle prices a move to roughly $98.11 or $88.73 from $93.42 by 10/30/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/05/2026 ±3.3% -1.6% over-priced
05/06/2026 ±4.1% -1.1% over-priced
02/11/2026 ±5.4% +4.1% over-priced
11/05/2025 ±5.6% +4.0% over-priced
08/04/2025 ±7.4% +1.0% over-priced
04/30/2025 ±4.7% -1.5% over-priced
02/12/2025 ±4.0% +1.2% over-priced
11/06/2024 ±3.6% -3.2% over-priced
Across these reports, options implied an average ±4.8% move vs an actual average of 2.2% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $3.52 $1.7B $480M
Q1 FY2026 $2.34 $1.4B $319M
Q4 FY2025 — $1.4B $-414M
Q3 FY2025 $-1.72 $1.3B $-161M
Analyst posture
Buy / Strong Buy
18
Hold
9
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Underweight · 43/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on ALB before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Albemarle Corporation (ALB) reports in 8 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±4.8% earnings move while the stock actually moved 2.2% on average — the market has systematically over-priced ALB's earnings risk. Fundamentals into the print: EPS up 2300.0% year-over-year, revenue up 31.1%. QuantLogix's live 5-factor engine currently reads ALB as a underweight at 43/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →